Hormonal contraception and thrombotic risk: a multidisciplinary approach

Area of Science:

• Adolescent Medicine
• Pharmacology
• Thrombosis Research

Background:

• Recent guidelines on hormonal contraception and thrombosis risk have prompted multidisciplinary discussions regarding adolescent care.
• The relative risk of thrombosis with combined oral contraceptives is elevated, but the absolute risk in healthy adolescents remains low.

Purpose of the Study:

• To review current literature and guidelines on hormonal contraception and thrombosis risk in adolescents.
• To outline a pediatric hospital's approach to managing adolescents with complex thrombosis risk factors.
• To discuss the application of absolute risk in counseling patients regarding contraceptive choices.

Main Methods:

• Literature review of hormonal contraception and thrombosis risk.
• Analysis of World Health Organization (2009) and Centers for Disease Control and Prevention (2010) guidelines.
• Summary of a hospital's multidisciplinary approach to patient management.

Main Results:

• The absolute annual thrombosis risk for healthy adolescents on combined oral contraceptives is approximately 0.05%.
• Thrombotic risk is influenced by estrogen dose, progestin type, delivery method, and therapy duration.
• Progestin-only pills and transdermal estradiol have minimal thrombotic risk; other methods require further study.

Conclusions:

• Individualized management plans informed by updated guidelines are essential for counseling adolescents on hormonal and nonhormonal contraceptive options.
• A thorough assessment of personal and family history of thrombosis and thrombophilia is critical.
• Multidisciplinary collaboration enhances the management of complex cases involving hormonal therapies and thrombosis risk.